– UK, Northwich – Dechra Pharmaceuticals PLC (LON: DPH) today announced the appointment of Denise Goode to its Board as a Non-Executive Director with effect from 26 April 2021.
“On behalf of the Board and all stakeholders I am delighted to welcome Denise to Dechra. She will add significant pharmaceutical and financial experience and capabilities to the team as well as providing continuity during the next phase of Dechra’s growth and development,” said Board Chairman, Tony Rice.
Denise will be a member of the Audit, Remuneration, and Nomination Committees and should be appointed as Chairman of the Audit Committee upon Julian Heslop’s retirement as Audit Committee Chairman following the 2021 Annual General Meeting.
About Denise Goode
Denise Goode brings a wealth of financial, commercial, and life science industry experience, both from her extensive career as a senior executive and from board roles held since 2008. She has a deep understanding of the pharmaceuticals sector and is highly experienced in business development.
Denise Goode is currently a Non-Executive Director of Abliva AB, a NASDAQ Sweden listed company, where she is Chair of the Remuneration Committee and a member of the Audit Committee. She is also VP, Business Development at AnaMar AB, a Swedish-based private company. In 2014 Denise Goode established QED Life Sciences Limited, through which as CEO she advises and supports the strategic direction of biotech companies. Before this, Denise Goode was Chair of the Audit Committee at Oxford Bioscience Network from 2014 to 2017 and AstraZeneca Ireland Operations Ltd from 2008 to 2013. Over her 20 years global career with AstraZeneca Pharmaceuticals PLC, Denise held senior leadership roles within the finance and commercial activities of the global entity.
She is a Fellow of the Institute of Chartered Accountants in England and Wales.
About Dechra Pharmaceuticals PLC
Dechra Pharmaceuticals PLC is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales, and marketing of high-quality products exclusively for veterinarians worldwide. Dechra’s business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.
For more information: https://www.dechra.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
